Alpha Tau price target raised to $12 from $9 at H.C. Wainwright

H.C. Wainwright expert Yi Chen raised the firm’s price target connected Alpha Tau (DRTS) to $12 from $9 and keeps a Buy standing connected the shares aft Japan’s Ministry of Health, Labour and Welfare granted selling support for Alpha DaRT for the attraction of unresectable locally precocious oregon locally recurrent caput and cervix cancer. The support successful Japan further validates the Alpha DaRT level and helps de-risk the objective improvement successful the U.S., the expert tells investors.

Claim 50% Off TipRanks Premium

• Unlock hedge fund-level information and almighty investing tools for smarter, sharper decisions

• Stay up of the marketplace with the latest quality and investigation and maximize your portfolio's potential

Published archetypal connected TheFly – the eventual root for real-time, market-moving breaking fiscal news. Try Now>>

See Insiders’ Hot Stocks connected TipRanks >>

Read More connected DRTS:

Disclaimer & DisclosureReport an Issue

• Alpha Tau Wins First Overseas Approval arsenic Japan Clears Alpha DaRT Cancer Therapy

• Alpha Tau announces Japan’s MHLW granted selling approbal for Alpha DaRT

• Alpha Tau Outlines Aggressive 2026 Clinical Schedule and Manufacturing Ramp for Alpha DaRT Cancer Therapy

• Alpha Tau issues missive to shareholders

• Alpha Tau Medical Unveils Strong Pancreatic Cancer Alpha DaRT Data Ahead of ASCO GI 2026